Historical salary details - Dr. Srikant M. Datar, PhD, Independent Director, T-Mobile US Inc
Dr. Srikant M. Datar, PhD is the Independent Director of T-Mobile US Inc. They also hold 2 other positions in ICF International, Inc and Stryker Corp..
Dr. Srikant M. Datar, Phd
Independent Director
$ 978.1 K
Gross Remuneration
-
Current Company
T-Mobile US Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | T-Mobile US Inc | Independent Director | 645.3 K | 10.3 % |
| 2024 | ICF International, Inc | Lead Independent Director | 290 K | 0.9 % |
| 2024 | Stryker Corp. | - | 42.8 K | -86.6 % |
| 2023 | T-Mobile US Inc | Independent Director | 584.8 K | 17.6 % |
| 2023 | Stryker Corp. | Independent Director | 319.2 K | -1.1 % |
| 2023 | ICF International, Inc | Lead Independent Director | 287.5 K | 4.5 % |
| 2022 | T-Mobile US Inc | Independent Director | 497.4 K | -18.0 % |
| 2022 | Stryker Corp. | Independent Director | 322.7 K | 11.8 % |
| 2022 | ICF International, Inc | Lead Independent Director | 275 K | 5.8 % |
| 2021 | T-Mobile US Inc | Independent Director | 606.7 K | -20.1 % |
| 2021 | Stryker Corp. | Independent Director | 288.6 K | 1.4 % |
| 2021 | ICF International, Inc | Lead Independent Director | 260 K | 14.4 % |
| 2021 | Novartis AG - ADR | Independent Director | - | - |
| 2020 | T-Mobile US Inc | Independent Director | 759.2 K | 63.1 % |
| 2020 | Novartis AG - ADR | Independent Director | 460.0 K | -0.0 % |
| 2020 | Stryker Corp. | Independent Director | 284.6 K | -1.9 % |
| 2020 | ICF International, Inc | Independent Director | 227.4 K | -3.3 % |
| 2019 | T-Mobile US Inc | Independent Director | 465.4 K | 22.2 % |
| 2019 | Novartis AG - ADR | Independent Director | 460 K | 0.4 % |
| 2019 | Stryker Corp. | Independent Director | 290.1 K | -0.0 % |
| 2019 | ICF International, Inc | Independent Director | 235.0 K | 6.8 % |
| 2018 | Novartis AG - ADR | Independent Director | 458.3 K | 0.7 % |
| 2018 | T-Mobile US Inc | Independent Director | 381.0 K | -19.2 % |
| 2018 | Stryker Corp. | Independent Director | 290.1 K | 2.6 % |
| 2018 | ICF International, Inc | Independent Director | 220.0 K | 5.3 % |
| 2017 | T-Mobile US Inc | Independent Director | 471.6 K | 29.9 % |
| 2017 | Novartis AG - ADR | Independent Director | 455 K | -5.2 % |
| 2017 | Stryker Corp. | Independent Director | 282.7 K | -0.6 % |
| 2017 | ICF International, Inc | Independent Director | 209 K | 5.6 % |
| 2016 | Novartis AG - ADR | Independent Director | 480 K | 0.0 % |
| 2016 | T-Mobile US Inc | Independent Director | 363.1 K | 14.1 % |
| 2016 | Stryker Corp. | Independent Director | 284.4 K | -7.5 % |
| 2016 | ICF International, Inc | Independent Director | 198 K | 2.6 % |
| 2015 | Novartis AG - ADR | Independent Director | 480 K | -7.7 % |
| 2015 | T-Mobile US Inc | Independent Director | 318.3 K | 5.1 % |
| 2015 | Stryker Corp. | Independent Director | 307.4 K | 6.5 % |
| 2015 | ICF International, Inc | Independent Director | 193 K | 2.7 % |
| 2014 | Novartis AG - ADR | Independent Director | 520 K | -27.8 % |
| 2014 | T-Mobile US Inc | Independent Director | 302.9 K | 51.4 % |
| 2014 | Stryker Corp. | Independent Director | 288.5 K | 0.9 % |
| 2014 | ICF International, Inc | Independent Director | 188 K | 38.2 % |
| 2013 | Novartis AG - ADR | Independent Director | 720.0 K | -0.0 % |
| 2013 | Stryker Corp. | Independent Director | 285.9 K | -2.4 % |
| 2013 | T-Mobile US Inc | Independent Director | 200.0 K | - |
| 2013 | ICF International, Inc | Independent Director | 136 K | -38.2 % |
| 2012 | Novartis AG - ADR | Independent Director | 720.1 K | -17.2 % |
| 2012 | Stryker Corp. | Independent Director | 293.0 K | -6.8 % |
| 2012 | ICF International, Inc | Independent Director | 220.0 K | -16.1 % |
| 2012 | T-Mobile US Inc | Independent Director | - | - |
| 2011 | Novartis AG - ADR | Independent Director | 869.8 K | - |
| 2011 | Stryker Corp. | Independent Director | 314.5 K | 5.3 % |
| 2011 | ICF International, Inc | Independent Director | 262.2 K | 40.8 % |
| 2010 | Stryker Corp. | Independent Director | 298.7 K | 27.9 % |
| 2010 | ICF International, Inc | Independent Director | 186.2 K | 99.7 % |
| 2010 | Novartis AG - ADR | Director | - | - |
| 2009 | Novartis AG - ADR | Director | 406.3 K | 13.8 % |
| 2009 | Stryker Corp. | Director | 233.6 K | - |
| 2009 | ICF International, Inc | Director | 93.2 K | -19.3 % |
| 2008 | Novartis AG - ADR | Director | 356.9 K | 35.0 % |
| 2008 | ICF International, Inc | Director | 115.5 K | 11.9 % |
| 2008 | Stryker Corp. | Director | - | - |
| 2007 | Novartis AG - ADR | Director | 264.4 K | -11.3 % |
| 2007 | ICF International, Inc | Director | 103.2 K | 405.7 % |
| 2006 | Novartis AG - ADR | Director | 298.1 K | -1.0 % |
| 2006 | ICF International, Inc | Director | 20.4 K | - |
| 2005 | Novartis AG - ADR | Director | 301 K | - |
| 2005 | ICF International, Inc | Director | - | - |
| 2004 | Novartis AG - ADR | Director | - | - |